Inventor
SIMEONE MICHAEL
US3 patents
Patents
3 patentsUS10752599B2Aug 25, 2020
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC3 citations82
US10100021B2Oct 16, 2018
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC4 citations82
US11718591B2Aug 8, 2023
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC1 citations70